Low-thrombogenic fibrin-heparin coating promotes in vitro endothelialization

J Biomed Mater Res A. 2017 Nov;105(11):2995-3005. doi: 10.1002/jbm.a.36152. Epub 2017 Aug 7.

Abstract

Long-term performance of implanted cardiovascular grafts can be ensured if living endothelium overgrows their surface. Surface modifications to implants are therefore being sought that can encourage endothelialization while preventing thrombus formation until the natural endothelium is formed. In the present study, heparin was covalently attached to a fibrin mesh grown from a polyvinyl chloride (PVC) substrate surface by the catalytic action of surface immobilized thrombin on a fibrinogen solution. The coating prevented platelet activation, thrombin generation and clot formation, and reduced inflammatory reactions when exposed to fresh human whole blood circulating in a Chandler loop model. In addition, in vitro seeded human umbilical vein and human saphenous vein endothelial cells showed considerably enhanced attachment and proliferation on the coating. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 2995-3005, 2017.

Keywords: endothelialization; fibrin-heparin coating; hemocompatibility; thrombogenicity; tissue engineering.

MeSH terms

  • Anticoagulants / chemistry*
  • Anticoagulants / pharmacology*
  • Blood Coagulation / drug effects
  • Blood Vessel Prosthesis / adverse effects
  • Cell Adhesion / drug effects
  • Cells, Cultured
  • Coated Materials, Biocompatible / chemistry*
  • Coated Materials, Biocompatible / pharmacology*
  • Endothelial Cells / cytology
  • Endothelial Cells / drug effects
  • Fibrin / chemistry
  • Hematocrit
  • Heparin / chemistry*
  • Heparin / pharmacology*
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Platelet Activation / drug effects
  • Saphenous Vein / cytology
  • Thrombosis / blood
  • Thrombosis / etiology
  • Thrombosis / prevention & control*

Substances

  • Anticoagulants
  • Coated Materials, Biocompatible
  • Fibrin
  • Heparin